Thomas W. Hudyma

Person

Manlius, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 7,547,690
- Issue date Jun 16, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,541,353
- Issue date Jun 2, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,521,441
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,485,633
- Issue date Feb 3, 2009
- Bristol-Myers Squibb Company
- Nicholas A. Meanwell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolobenzazepine HCV NS5B inhibitors
- Patent number 7,473,688
- Issue date Jan 6, 2009
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV NS5B inhibitors
- Patent number 7,456,165
- Issue date Nov 25, 2008
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,399,758
- Issue date Jul 15, 2008
- Nicholas A. Meanwell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,348,425
- Issue date Mar 25, 2008
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,153,848
- Issue date Dec 26, 2006
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
O-derivatized nocathiacin derivatives
- Patent number 7,022,667
- Issue date Apr 4, 2006
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful for treating hepatitis C virus
- Patent number 6,803,374
- Issue date Oct 12, 2004
- Bristol-Myers Squibb Company
- Eldon Scott Priestley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Water soluble prodrugs of azole compounds
- Patent number 6,620,934
- Issue date Sep 16, 2003
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Water soluble prodrugs of azole compounds
- Patent number 6,620,799
- Issue date Sep 16, 2003
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Water soluble prodrugs of azole compounds
- Patent number 6,486,159
- Issue date Nov 26, 2002
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Water soluble prodrugs of azole compounds
- Patent number 6,458,961
- Issue date Oct 1, 2002
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Water soluble prodrugs of azole compounds
- Patent number 6,362,172
- Issue date Mar 26, 2002
- Bristol-Myers Squibb Company
- Yasutsugu Ueda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Water soluble prodrugs of azole compounds
- Patent number 6,359,141
- Issue date Mar 19, 2002
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Water soluble prodrugs of azole compounds
- Patent number 6,265,584
- Issue date Jul 24, 2001
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cephalosporin derivatives
- Patent number 6,093,712
- Issue date Jul 25, 2000
- Bristol-Meyers Squibb Company
- John D. Matiskella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphonomethoxy carbocyclic nucleosides and nucleotides
- Patent number 5,744,600
- Issue date Apr 28, 1998
- Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of...
- Muzammil M. Mansuri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cephalosporin derivatives
- Patent number 5,668,284
- Issue date Sep 16, 1997
- Bristol-Myers Squibb Company
- Choung U. Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridinium thiomethyl substituted chepholosporin derivatives
- Patent number 5,567,698
- Issue date Oct 22, 1996
- Bristol-Myers Squibb Company
- Choung U. Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cephalosporin derivatives
- Patent number 5,559,108
- Issue date Sep 24, 1996
- Bristol-Myers Squibb Company
- Choung U. Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Injectable compositions of cefepime dihydrochloride hydrate
- Patent number 5,244,891
- Issue date Sep 14, 1993
- Bristol-Myers Squibb Company
- Murray A. Kaplan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediates for cyclobutenedione substituted (1-carba)cephalospor...
- Patent number 5,206,360
- Issue date Apr 27, 1993
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibiotic C-3 cyclobutenedione substituted (1-carba) cephalosporin...
- Patent number 5,169,843
- Issue date Dec 8, 1992
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibiotic C-3 cyclobutenedione substituted (1-carba)cephalosporin...
- Patent number 5,106,842
- Issue date Apr 21, 1992
- Bristol-Myers Squibb Co.
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cephalosporin salts and injectable compositions
- Patent number 4,994,451
- Issue date Feb 19, 1991
- Bristol-Myers Company
- Murray A. Kaplan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cefepime cephalosporin salts
- Patent number 4,910,301
- Issue date Mar 20, 1990
- Bristol-Myers Company
- Murray A. Kaplan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ulcer agents
- Patent number 4,457,932
- Issue date Jul 3, 1984
- Bristol-Myers Company
- Peter F. Juby
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080227769
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080226591
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070270406
- Publication date Nov 22, 2007
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HCV NS5B Inhibitors
- Publication number 20070185083
- Publication date Aug 9, 2007
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070184024
- Publication date Aug 9, 2007
- Bristol -Myers Squibb Company
- Nicholas A. Meanwell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indolobenzazepine HCV NS5B inhibitors
- Publication number 20070078122
- Publication date Apr 5, 2007
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Publication number 20070060565
- Publication date Mar 15, 2007
- Bristol -Myers Squibb Company
- Nicholas A. Meanwell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HCV replication
- Publication number 20060166964
- Publication date Jul 27, 2006
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HCV replication
- Publication number 20060046983
- Publication date Mar 2, 2006
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HCV replication
- Publication number 20050119318
- Publication date Jun 2, 2005
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds useful for treating Hepatitis C virus
- Publication number 20040067976
- Publication date Apr 8, 2004
- Eldon Scott Priestley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
O-derivatized nocathiacin derivatives
- Publication number 20040018963
- Publication date Jan 29, 2004
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds useful for treating hepatitis C virus
- Publication number 20030134853
- Publication date Jul 17, 2003
- Eldon Scott Priestley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Water soluble prodrugs of azole compounds
- Publication number 20020049216
- Publication date Apr 25, 2002
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cephalosporin derivatives
- Publication number 20020049191
- Publication date Apr 25, 2002
- Dane M. Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Water soluble prodrugs of azole compounds
- Publication number 20020049336
- Publication date Apr 25, 2002
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Water soluble prodrugs of azole compounds
- Publication number 20020049334
- Publication date Apr 25, 2002
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Water soluble prodrugs of azole compounds
- Publication number 20010041691
- Publication date Nov 15, 2001
- Yasutsugu Ueda
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Water soluble prodrugs of azole compounds
- Publication number 20010039353
- Publication date Nov 8, 2001
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Water soluble prodrugs of azole compounds
- Publication number 20010012843
- Publication date Aug 9, 2001
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY

Thomas W. Hudyma

Person

Patents Grantslast 30 patents

Compounds for the treatment of Hepatitis C

Compounds for the treatment of hepatitis C

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Indolobenzazepine HCV NS5B inhibitors

HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Inhibitors of HCV replication

Inhibitors of HCV replication

O-derivatized nocathiacin derivatives

Compounds useful for treating hepatitis C virus

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Cephalosporin derivatives

Phosphonomethoxy carbocyclic nucleosides and nucleotides

Cephalosporin derivatives

Pyridinium thiomethyl substituted chepholosporin derivatives

Cephalosporin derivatives

Injectable compositions of cefepime dihydrochloride hydrate

Intermediates for cyclobutenedione substituted (1-carba)cephalospor...

Antibiotic C-3 cyclobutenedione substituted (1-carba) cephalosporin...

Antibiotic C-3 cyclobutenedione substituted (1-carba)cephalosporin...

Cephalosporin salts and injectable compositions

Cefepime cephalosporin salts

Anti-ulcer agents

Patents Applicationslast 30 patents

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Indolobenzazepine HCV NS5B inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Inhibitors of HCV replication

Inhibitors of HCV replication

Inhibitors of HCV replication

Compounds useful for treating Hepatitis C virus

O-derivatized nocathiacin derivatives

Compounds useful for treating hepatitis C virus

Water soluble prodrugs of azole compounds

Cephalosporin derivatives

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds

Water soluble prodrugs of azole compounds